Paloma Partners’s Alignment Healthcare ALHC Stock Holding History

Paloma Partners’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,662	Closed	-$131K	–	1084
2022 Q1	$131K	Buy	+11,662	New	+$105K	﹤0.01%	1527

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Paloma Partners's ALHC Position: Q2 2022 in Review

Paloma Partners sold out of Alignment Healthcare (ALHC) in Q2 2022, closing a stake of 11,662 shares — an estimated $131K sold.

Paloma Partners first reported a position in ALHC in Q1 2022 and held it in 1 quarter. The position peaked at $131K in Q1 2022. 92 funds tracked by Wall St. Rank hold ALHC as of Q2 2022.

Paloma Partners reported no remaining Alignment Healthcare position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 11,662 Alignment Healthcare shares in Q2 2022, an estimated $131K.
Paloma Partners first reported a position in Alignment Healthcare in Q1 2022 and held it in 1 quarter.
Paloma Partners's Alignment Healthcare position peaked at $131K in Q1 2022.
92 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.